CHICAGO Adding prostate irradiation to standard systemic therapy extended radiographic PFS among men with newly diagnosed low-volume metastatic castration-sensitive prostate cancer, according to results of the PEACE-1 trial. Although the regimen did not confer an OS benefit, the addition of radiation therapy to an intensified standard-of-care regimen produced the best efficacy and safety
/PRNewswire/ The "Antibody Drug Conjugates Global Market Report 2022: By Type, By Application, By Product, By Technology, By End-User" report has been added.